Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (14794)	12/19/2004 2:23:55 PM
From: zeta1961	Read Replies (2) \| Respond to of 52153

Is this amount of injury and death really acceptable for an over-the-counter pain reliever? Thanks for posting the tyl/liver failure abstract..it affirms for me this statement I made Friday..I was basing my opinion on my experience in the hosptital and from 10-15 year old data... <<IMHO, Tylenol is more dangerous as an OTC than these coxibs...do you know how many deaths/hospitalizations occur on an annual basis for non-suicidal intended overdoses?>> Zeta PS..Monette and Doc..I happen to be a Zantac/Ranitidine fan..although it's twice a day dosing, perhaps an alternative while Prilosec is on back order?..